Home/Filings/4/0001209191-22-027079
4//SEC Filing

Veness Adam M 4

Accession 0001209191-22-027079

CIK 0001662244other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 4:22 PM ET

Size

5.5 KB

Accession

0001209191-22-027079

Insider Transaction Report

Form 4
Period: 2022-05-02
Veness Adam M
General Counsel
Transactions
  • Award

    Stock Option (Right to buy)

    2022-05-02+177,000177,000 total
    Exercise: $2.35Exp: 2032-04-25Common Stock (177,000 underlying)
Footnotes (1)
  • [F1]The shares of common stock underlying this stock option award vest as to 25% on April 25, 2023, and 2.083% in 36 monthly installments thereafter, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.

Issuer

Cyteir Therapeutics, Inc.

CIK 0001662244

Entity typeother

Related Parties

1
  • filerCIK 0001778623

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:22 PM ET
Size
5.5 KB